泰州致力构建生物医药全链条知识产权协同保护生态
Xin Hua Ri Bao·2025-12-11 21:50

Core Insights - The event held during the 16th Taizhou Pharmaceutical Expo focused on building a collaborative ecosystem for intellectual property (IP) protection across the entire biopharmaceutical industry chain, aiming to inject new momentum into industrial innovation and development [1][2] Group 1: Collaborative Initiatives - A cross-regional "1+4+N" collaborative IP protection system for the biopharmaceutical industry was established, involving the Jiangsu Provincial IP Protection Center and four cities: Nanjing, Suzhou, Lianyungang, and Taizhou [1] - The establishment of the Netherlands Workstation by the National Overseas Intellectual Property Dispute Response Guidance Jiangsu Sub-center aims to provide professional guidance and protection for enterprises venturing into international markets [2] Group 2: Industry Development Strategies - Taizhou will focus on three key areas: cross-regional collaboration, overseas protection, and patent empowerment to enhance the influence and voice of its biopharmaceutical industry [2] - The event included the signing of multiple cooperation projects between enterprises and universities, promoting the transformation of scientific and technological achievements [2] Group 3: Policy and Guidance - The event featured a presentation on how IP protection can empower high-quality development in the biopharmaceutical industry, outlining key objectives such as early resolution of innovation results and adapting to collective procurement environments [3] - The Jiangsu Provincial and Taizhou IP Protection Centers provided specialized interpretations on overseas IP protection and corporate trade secret protection, offering practical guidance for enterprises [3]

泰州致力构建生物医药全链条知识产权协同保护生态 - Reportify